Skip to main content
. 2024 Mar 30;28(4):387–392. doi: 10.5005/jp-journals-10071-24687

Table 2.

Performance of DAST compared with reference AST method for Enterobacterales by VITEK-2 system

Enterobacterales (60) Categorical agreement, n (%) Categorical disagreement n (%) Essential agreement
Minor error Major error Very major error Total Agreed Disagreed
Cefoperazone sulbactam 60 (100.0%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 60 (100%) 0 (0.0%)
Amoxicillin/clavulanic acid 60 (100.0%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 60 (100%) 0 (0.0%)
Piperacillin/tazobactam 60 (100.0%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 60 (100%) 0 (0.0%)
Cefuroxime 60 (100.0%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 60 (100%) 0 (0.0%)
Cefuroxime axetil 60 (100.0%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 60 (100%) 0 (0.0%)
Cefepime 60 (100.0%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 60 (100%) 0 (0.0%)
Ceftriaxone 60 (100.0%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 60 (100%) 0 (0.0%)
Imipenem 54 (90.0%) 2 (3.3%) 4 (6.7%) 0 (0.0%) 6 (10.0%) 57 (95%) 3 (5.0%)
Meropenem 59 (98.3%) 0 (0.0%) 1 (1.7%) 0 (0.0%) 1 (1.7%) 58 (96.7%) 2 (3.3%)
Amikacin 60 (100.0%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 60 (100%) 0 (0.0%)
Gentamicin 59 (98.3%) 0 (0.0%) 1 (1.7%) 0 (0.0%) 1 (1.7%) 58 (96.7%) 2 (3.3%)
Ciprofloxacin 60 (100.0%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 60 (100%) 0 (0.0%)
Tigecycline 60 (100.0%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 60 (100.0%) 0 (0.0%)
Colistin 60 (100.0%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 60 (100.0%) 0 (0.0%)
Cotrimoxazole 60 (100.0%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 60 (100.0%) 0 (0.0%)